|
"lee bin shyun"的相关文件
显示项目 1-6 / 6 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-05-12T07:37:59Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
Shao, Yu-Yun; Chen, Pai-Sheng; LIANG-IN LIN; Lee, Bin-Shyun; Ling, Andrew; Cheng, Ann-Lii; CHIUN HSU; Ou, Da-Liang |
| 臺大學術典藏 |
2022-03-14T23:45:18Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
YU-YUN SHAO; Chen, Pai Sheng; LIANG-IN LIN; Lee, Bin Shyun; Ling, Andrew; ANN-LII CHENG; CHIUN HSU; DA-LIANG OU |
| 臺大學術典藏 |
2021-04-21T23:30:44Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
DA-LIANG OU; Chen, Chia Wei; Chia-Lang Hsu; Chung, Chih Hung; Feng, Zi Rui; Lee, Bin Shyun; ANN-LII CHENG; Yang, Muh Hwa; CHIUN HSU |
| 國立臺灣大學 |
2015 |
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Ou, Da-Liang; Shyue, Song-Kun; Lin, Liang-In; Feng, Zi-Rui; Liou, Jun-Yang; Fan, Hsiang-Hsuan; Lee, Bin-Shyun; Hsu, Chiun; Cheng, Ann-Lii; 林亮音; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2014 |
Vertical blockade of the IGFR-PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
|
Ou, Da-Liang; Lee, Bin-Shyun; Lin, Liang-In; Liou, Jun-Yang; Liao, Sheng-Chieh; Hsu, Chiun; Cheng, Ann-Lii; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2013 |
Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway
|
Ou, Da-Liang; Lee, Bin-Shyun; Chang, Ya-Chi; Lin, Liang-In; Liou, Jun-Yang; Hsu, Chiun; Cheng, Ann-Lii; 林亮音; 鄭安理; 許駿; 歐大諒 |
显示项目 1-6 / 6 (共1页)
1
每页显示[10|25|50]项目
|
